In addition to its comprehensive private market sales monitors, AMS offers a unique service: Institutional (Tender) Studies. These quarterly reports provide businesses with an in-depth analysis of public procurement activities within the pharmaceutical industry. This service complements AMS’ existing offerings and delivers an unparalleled holistic view of both private and public market dynamics.

AMS meticulously analyzes all tenders awarded by and delivered to the Iraqi Ministry of Health (KIMADIA), ensuring an accurate and reliable display of data. By understanding government priorities and purchasing patterns, businesses can identify potential opportunities and niche markets within the public sector.

Institutional data offers valuable insights not only for pharmaceutical manufacturers and distributors, but also to healthcare investors, analysts, and market research agencies.

By combining private and public data, businesses gain a comprehensive understanding of the entire pharmaceutical market landscape in Iraq.

Currently, AMS Institutional Studies are available for the Iraqi pharmaceutical market. However, AMS is actively expanding its reach and will soon offer an institutional study for the Jordanian market.